Treatment for genetic pancreatic cancer
Researchers at Israel’s Sheba Medical Center have had positive results in trials of Lynparza (olaparib) for treating pancreatic cancer in carriers of BRCA mutations. An international trial of 154 patients showed improved response, time to progression and quality of life.
New early test for Parkinson’s
Tel Aviv University scientists have discovered a new method for detecting the aggregation of the protein alpha-synuclein, before Parkinson’s symptoms appear. Doctors can then monitor how treatments affect this aggregation.
Transmitting neural messages to the next generation
Researchers at Tel Aviv University have identified a nervous system mechanism that can transmit neural messages to future generations. They showed that data on environmental factors are stored in brain cells (neurons) and expressed in germline genes to one’s children.
US approval for soft Exo-suit
Last week ReWalk’s soft exoskeleton received European (CE) approval. This week, the US FDA approved the Israeli innovation. Things are “looking up” for stroke victims.
Tracking response to cancer treatment
Israel-based Techsomed develops an image analysis system that helps track tissue response to thermal ablation - the process of destroying tumors using extreme heat or cold. It works with ultrasound to simulate the effects over time and provide surgeons with better control and accuracy.
Israeli diet is good for the brain
I reported previously that Israel has the lowest rate of diet-related deaths in the world. Now, the American Academy of Neurology medical journal has found that the diet can also help preserve memory and thinking abilities.
Foolproof Ambulance inventory list
Three students from Jerusalem College of Technology won first prize at the college’s third annual Great Minds hackathon. They devised a system using sensors to eliminate human error when checking crucial inventory on ambulances before they are dispatched from their stations.
Treatment for resistant Myeloma
Israel’s Pi Therapeutics (PiTx) is developing a treatment for PI-resistant Multiple Myeloma (MM) and solid tumors. Its small molecule non-catalytic UPS inhibitors have worked in lab tests. MM is an incurable blood cancer. PiTx has just raised $19.7 million for a formal clinical proof of concept.
SACH’s 5,000th patient
1-year-old Fatima from Zanzibar is the 5,000th child (from 60 countries) to be treated (for free) by Israeli charity Save A Child’s Heart. Ironically, 19 years ago, SACH surgeons gave Fatima’s 26-year-old mother, Balkis, life-saving treatment at the same Israeli hospital for the same condition.
Doctors save toddler choking on popcorn
Specialists at Schneider Children’s Hospital managed to successfully extract popcorn from the airways of 2-year-old Ori Adler. Doctors and nurses extracted the small and sharp popcorn pieces that were stuck in the child’s airways using delicate bronchoscopy.